Jason Tardio - Sep 12, 2022 Form 4 Insider Report for Ovid Therapeutics Inc. (OVID)

Role
Chief Operating Officer
Signature
/s/ Danielle Mann for Jason Tardio by PoA
Stock symbol
OVID
Transactions as of
Sep 12, 2022
Transactions value $
-$37,290
Form type
4
Date filed
9/14/2022, 04:58 PM
Previous filing
Apr 12, 2022
Next filing
Feb 27, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OVID Common Stock Sale -$37.3K -17.3K -100% $2.15 0 Sep 12, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person acquired the shares pursuant to the Issuer's employee stock purchase plan. These transactions were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Following the reported transaction, the Reporting Person will hold no ESPP shares.